Indicated for the treatment of chronic Hepatitis C (CHC) in adults: 🦠 Pan-genotypic: Used for genotypes 1, 2, 3, 4, 5, and 6. 🏥 Advanced Liver Disease: Effective in patients with cirrhosis (compensated and decompensated). 🛡️ Special Populations: Safe for patients co-infected with HIV and those awaiting liver transplantation.

Dosage and administration

Packaging: 400 mg film-coated tablets. ⚠️ ADMINISTRATION PROTOCOL: 💊 Dose: One tablet (400 mg) orally once daily. 🕒 Consistency: Take at the same time every day to prevent viral breakthrough. 🍲 Usage: May be taken with or without food. Swallow whole (do not chew or crush due to bitter taste). 📅 Duration: Typically 12 weeks. Extended to 24 weeks for difficult-to-treat patients.

Monotherapy: Must be used in combination with other antiviral agents. ❤️ Drug Interaction: Co-administration with Amiodarone is contraindicated due to risk of severe symptomatic bradycardia. Pregnancy and breastfeeding. Use with potent P-gp inducers (e.g., Rifampin, St. John's Wort).

Sofosbuvir has a favorable safety profile. Common adverse events include: 💤 General: Fatigue, irritability. 🤯 Neurological: Headache, insomnia. 🤢 Gastrointestinal: Nausea. ⚠️ Note: Most side effects are mild and transient.

Sofoxen — Sofosbuvir 400 mg, 28 pcs, Everest

100% original product

Active ingredient

Sofosbuvir

Manufacturer

Everest

Dosage 400 mg

Dosage form Tablets

Tablets per pack 28

Sofoxen (Sofosbuvir) Tablets

Name: Sofoxen
Brand: Everest
SKU: PROD-130
Price: 3955 UAH
Availability: InStock

3955₴ ~~4834₴~~ -18%

Sofoxen 400 mg (Sofosbuvir) is a nucleotide analog NS5B polymerase inhibitor, acting as the backbone of modern Hepatitis C treatment regimens.

Manufacturer: Everest Pharmaceuticals. Each pack contains 28 tablets. It works by terminating the viral replication process directly within the liver cells.

Crucial Information:

Sofosbuvir is not a monotherapy. To cure Hepatitis C, it must always be combined with another Direct-Acting Antiviral (DAA) such as Daclatasvir, Ledipasvir, or Velpatasvir.

✅ Benefit: Essential component for curing HCV across all genotypes (1–6) with high efficacy rates (>95%).

Indicated for the treatment of chronic Hepatitis C (CHC) in adults:

🦠 Pan-genotypic: Used for genotypes 1, 2, 3, 4, 5, and 6.
🏥 Advanced Liver Disease: Effective in patients with cirrhosis (compensated and decompensated).
🛡️ Special Populations: Safe for patients co-infected with HIV and those awaiting liver transplantation.

Packaging: 400 mg film-coated tablets.

⚠️ ADMINISTRATION PROTOCOL:

💊 Dose: One tablet (400 mg) orally once daily.
🕒 Consistency: Take at the same time every day to prevent viral breakthrough.
🍲 Usage: May be taken with or without food. Swallow whole (do not chew or crush due to bitter taste).
📅 Duration: Typically 12 weeks. Extended to 24 weeks for difficult-to-treat patients.

Monotherapy: Must be used in combination with other antiviral agents.
❤️ Drug Interaction: Co-administration with Amiodarone is contraindicated due to risk of severe symptomatic bradycardia.
Pregnancy and breastfeeding.
Use with potent P-gp inducers (e.g., Rifampin, St. John's Wort).

Sofosbuvir has a favorable safety profile. Common adverse events include:

💤 General: Fatigue, irritability.
🤯 Neurological: Headache, insomnia.
🤢 Gastrointestinal: Nausea.
⚠️ Note: Most side effects are mild and transient.

Notice. The information on this page is for reference only and does not replace medical consultation. Always consult a healthcare professional and read the manufacturer's instructions before using any medicine. Self-medication may be dangerous. Information updated: 13.03.2026